BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6316372)

  • 1. N-allylnormetazocine (SKF-10,047): the induction of feeding by a putative sigma agonist.
    Gosnell BA; Levine AS; Morley JE
    Pharmacol Biochem Behav; 1983 Nov; 19(5):737-42. PubMed ID: 6316372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization.
    Colpaert FC; Janssen PA
    J Pharmacol Exp Ther; 1984 Jul; 230(1):193-9. PubMed ID: 6747824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between narcotic agonists, partial agonists andd antagonists evaluated by punished an unpunished behavior in the rat.
    Snell D; Harris RA
    Psychopharmacology (Berl); 1982; 76(2):177-81. PubMed ID: 6281840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kappa opioid receptor and food intake.
    Morley JE; Levine AS; Kneip J; Grace M; Zeugner H; Shearman GT
    Eur J Pharmacol; 1985 May; 112(1):17-25. PubMed ID: 2990965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concerning the specificity of the hypothalamic opiate receptor responsible for food intake in the rat.
    Tepperman FS; Hirst M
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1141-4. PubMed ID: 6298827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential neuropharmacological effects of mu, kappa and sigma opioid agonists on cortical EEG power spectra in the rat. Stereospecificity and naloxone antagonism.
    Young GA; Khazan N
    Neuropharmacology; 1984 Oct; 23(10):1161-5. PubMed ID: 6097833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of morphine, ethylketocyclazocine, N-allylnormetazocine and naloxone on locomotor activity in the rabbit.
    Schindler CW; White MF; Goldberg SR
    Psychopharmacology (Berl); 1990; 101(2):172-7. PubMed ID: 2190257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of morphine, ethylketocyclazocine, and N-allylnormetazocine on classical conditioning of the rabbit nictitating membrane response.
    Schindler CW; Lamb MR; Gormezano I; Harvey JA
    Behav Neurosci; 1986 Oct; 100(5):647-51. PubMed ID: 3535828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus properties of nalorphine in the rhesus monkeys.
    Tang AH; Code RA
    J Pharmacol Exp Ther; 1983 Dec; 227(3):563-9. PubMed ID: 6317838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar anticonvulsant, but unique, behavioural effects of opioid agonists in the seizure-sensitive Mongolian gerbil.
    Lee RJ; Bajorek JG; Lomax P
    Neuropharmacology; 1984 May; 23(5):517-24. PubMed ID: 6330606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic effects of N-allylnormetazocine (SKF-10047).
    Iwamoto ET
    NIDA Res Monogr; 1981 Feb; 34():82-8. PubMed ID: 6783955
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3.
    Pechnick R; George R; Poland RE
    J Pharmacol Exp Ther; 1985 Jan; 232(1):170-7. PubMed ID: 2981314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reinforcing properties of stereoisomers of the putative sigma agonists N-allylnormetazocine and cyclazocine in rhesus monkeys.
    Slifer BL; Balster RL
    J Pharmacol Exp Ther; 1983 Jun; 225(3):522-8. PubMed ID: 6306209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of opioid receptors in hypo- and hyperthermic effects induced by phencyclidine in mice.
    Hiramatsu M; Nabeshima T; Kameyama T
    J Pharmacobiodyn; 1986 May; 9(5):466-72. PubMed ID: 3020223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous assessment of the opiate-induced modifications in the vertical and horizontal components of locomotor activity in mice.
    Chaillet P; Durand MA; Marçais-Collado H; Costentin J
    J Pharmacol; 1984; 15(3):375-83. PubMed ID: 6092786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effects of opioid agonists and antagonists under a fixed-consecutive-number schedule in rats.
    Picker M; Heise JW; Dykstra LA
    Pharmacol Biochem Behav; 1987 May; 27(1):73-80. PubMed ID: 3615550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative stimulus effects of prototype opiate receptor agonists in monkeys.
    Teal JJ; Holtzman SG
    Eur J Pharmacol; 1980 Nov; 68(1):1-10. PubMed ID: 6256182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple opiate receptors for multiple opioid peptides.
    Miller RJ
    Med Biol; 1982 Feb; 60(1):1-6. PubMed ID: 6121959
    [No Abstract]   [Full Text] [Related]  

  • 20. An investigation of the role of kappa opiate receptor agonists in the initiation of feeding.
    Morley JE; Levine AS; Grace M; Kniep J
    Life Sci; 1982 Dec; 31(23):2617-26. PubMed ID: 6296586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.